Carcinoma, Non-Small-Cell Lung: all 6,641 studies

Page 6 of 67. Open to participants first (1,665), then studies with results posted, then the rest; newest registration first within each.

• A Phase 3 Study of IN10018 in Combination With D-1553 Versus Standard Therapy for First Line Non-squamous Non-small Cell Lung Cancer With KRAS G12C MutationRecruitingNCT07174908Phase 3
• An External Control Arm Study in Non-Small Cell Lung CancerRecruitingNCT07174388
• A Real-world Study of Adebrelimab-based Combination Regimens in the Treatment of Advanced Solid TumorsNot yet recruitingNCT07173244
• A Study of GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as Monotherapy in Patients With Advanced or Metastatic Solid TumorsRecruitingNCT07172802Phase 1/2
• Phase III Study of SHR-8068 Combined With Adebrelimab and Chemotherapy Versus Tislelizumab Combined With Chemotherapy in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung CancerRecruitingNCT07170995Phase 3
• A Study of YL202 in Combination With Other Anti-tumor Therapies in Patients With Advanced Solid TumorsRecruitingNCT07169994Phase 1/2
• M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid TumorsRecruitingNCT07166601Phase 1
• Efficacy of Neoadjuvant Immunotherapy in Patients With Lung CancerRecruitingNCT07166003
• A Study of ZW251 in Participants With Advanced Solid TumorsRecruitingNCT07164313Phase 1
• A Phase 2 Clinical Study of Combination Therapy With ABSK043 and GlecirasibRecruitingNCT07164170Phase 2
• Immune Response to Immunotherapy in Lung Cancer: Study of Sputum and Blood SamplesNot yet recruitingNCT07163507Not applicable
• ALG-LungCancerRegistry (SAFRO2202)RecruitingNCT07161882
• Urolithin A in Patients With Previously Untreated Solid Tumors Receiving Immune Checkpoint InhibitorsRecruitingNCT07161310Not applicable
• Athletic Intervention After THoracic surgEry for luNg cAncer: a Pilot StudyNot yet recruitingNCT07159646Not applicable
• AK112 in Non-squamous Non-small Cell Lung Cancer (NSCLC)Patients With Actionable Genomic Alterations (AGA) Who Have Failed to Previous Tyrosine Kinase Inhibitor (TKI) TreatmentNot yet recruitingNCT07158840Phase 2
• Overcoming Resistance to Immunotherapy Combining Gemcitabine With Ivonescimab in Advanced NSCLCRecruitingNCT07158489Phase 2
• A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung CancerRecruitingNCT07155187Phase 2/3
• Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)RecruitingNCT07154706Phase 3
• JYP0322 Versus Platinum Based Doublet Chemotherapy in ROS1 Positive Patients Previously Treated With ROS1-TKIs.Not yet recruitingNCT07154368Phase 3
• A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)RecruitingNCT07154290Phase 2
• Neoadjuvant Treatment With Atezolizumab and Atezolizumab as Maintenance for the Treatment of Stage III Non Small-Cell Lung Cancer (NSCLC)RecruitingNCT07153445Phase 2
• Phase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid TumorsRecruitingNCT07151040Phase 1/2
• Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung CancerRecruitingNCT07150663Phase 3
• Immune-Marker Platform for Patients With Advanced Lung CancerNot yet recruitingNCT07150598
• Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC)RecruitingNCT07149649Phase 2/3
• Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.RecruitingNCT07148128Phase 1/2
• The Selective Personalized Radio-Immunotherapy for Locally Advanced Non-Small Cell Lung Cancer Trial 2Not yet recruitingNCT07146230Phase 2
• Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid TumorsRecruitingNCT07145255Phase 1/2
• A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)RecruitingNCT07144280Phase 3
• DK222 Study at HopkinsRecruitingNCT07140315Phase 1
• A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)RecruitingNCT07140016Phase 1
• Iparomlimab and Tuvonralimab Plus Chemotherapy for Inducing Conversion to Resectability in Initially Unresectable Stage III NSCLCNot yet recruitingNCT07139041Phase 2
• The Efficacy and Safety of the Combination of PD-1 With Chemotherapy and Adaptive Radiotherapy Strategy in the Treatment of Stage III Non-small Cell Lung Cancer PatientsRecruitingNCT07138755Phase 2
• Primary Radiotherapy In MEtastatic Lung CancerRecruitingNCT07135882Phase 3
• A Phase 2 Platform Study of Immunomodulatory Compounds in ICI-refractory Non-small Cell Lung CancerRecruitingNCT07133425Phase 2
• HEARTS Trial for Thoracic CancersRecruitingNCT07132918Phase 2
• SFRT+Tislelizumab+Platinum Chemotherapy for Unresectable Stage III NSCLCRecruitingNCT07131319Phase 2/3
• Real World Stage II-III NSCLC Patients Receiving Neoadjuvant Chemo-immunotherapy and no Surgical ResectionRecruitingNCT07131163
• A Study of Aumolertinib in European Participants With Non-Small Cell Lung CancerRecruitingNCT07130916Phase 1
• Efficacy And Safety Of Anti-PD-1/PD-L1 Antibodies In Combination With Bevacizumab And Metronomic Cyclophosphamide In Patients With Non-Small Cell Lung Cancer And Cutaneous Melanoma Previously Treated With Immune Checkpoint BlockadeRecruitingNCT07130032Phase 2
• Iparomlimab and Tuvonralimab Combined With 2 or 4 Cycles of Chemotherapy as Neoadjuvant Therapy for Resectable NSCLCNot yet recruitingNCT07129161Phase 2
• A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor ResectionRecruitingNCT07128199Phase 3
• A Study of PHN-012 in Patients With Advanced Solid TumorsRecruitingNCT07127874Phase 1
• Early Feasibility Study (EFS) of the 'CAROL' for Treatment of Lung Cancer Stage 1RecruitingNCT07122258Not applicable
• Adaptive Adjuvant Sintilimab Therapy Guided by MRD (ADAPT Lung)RecruitingNCT07120698Phase 2
• Study to Evaluate the Efficacy and Safety of Adjuvant Tislelizumab in High-Risk Stage I NSCLCRecruitingNCT07120282Phase 2
• A Perioperative Comprehensive Diagnosis and Treatment System for Lung Cancer in the Era of Neoadjuvant ImmunotherapyNot yet recruitingNCT07119190
• Sunvozertinib Treatment in Untreated Advanced NSCLC With EGFR Uncommon MutationsRecruitingNCT07117890Phase 2
• A Phase I Study of [68Ga]Ga-DWJ155 in Patients With Breast and Lung CancersRecruitingNCT07117214Phase 1
• MOv19-BBz CAR T Cells in FRa+ CancersRecruitingNCT07116057Phase 1
• A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid TumorsRecruitingNCT07115043Phase 1/2
• A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)RecruitingNCT07111520Phase 1/2
• A Clinical Study of BT02 in Treating Patients With Advanced Lung CancerNot yet recruitingNCT07110363Phase 1
• ASKC202 Combined With Limertinib Versus Platinum-based Chemotherapy in Treatment of Locally Advanced or Metastatic NSCLC With MET Amplification/Overexpression After Failure of EGFR-TKI TherapyRecruitingNCT07109531Phase 3
• A Study of GV20-0251 in Advanced or Refractory Solid TumorsRecruitingNCT07106827Phase 1
• Pulmonary Rehabilitation in Advanced Lung Cancer SurvivorsRecruitingNCT07104630Phase 2
• A Study Evaluating Neoadjuvant Chemotherapy, Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade in Patients With Locally Advanced Non-Small Cell Lung CancerRecruitingNCT07103395Phase 2
• Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)RecruitingNCT07100080Phase 2/3
• The Lung Health Check PilotRecruitingNCT07099027Not applicable
• A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)RecruitingNCT07098338Phase 2
• SDTM001 Injection as Adjuvant Therapy for NSCLC Patients After Radical Surgical ResectionRecruitingNCT07096882Phase 1
• EMPATHY NSCLC: European Registry for Plasma-Based Molecular Profiling in Advanced NSCLC PatientsRecruitingNCT07096258
• A Study to Find a Suitable Dose of ASP5834 in Adults With Solid TumorsRecruitingNCT07094204Phase 1
• AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid TumorsRecruitingNCT07094113Phase 1
• Efficacy and Safety Analysis of First-Line ABCP Therapy in Advanced SMARCA4-Mutated NSCLCNot yet recruitingNCT07093762
• A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid TumorsRecruitingNCT07090499Phase 1
• Combination of Concurrent Chemoradiotherapy With Surufatinib and Tislelizumab in Patients With Locally Advanced Non-Small Cell Lung CancerRecruitingNCT07086456Phase 2
• Electroacupuncture Combined With PD-1 Inhibitor for Elderly Patients With Advanced NSCLCRecruitingNCT07086300Not applicable
• A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid TumorsRecruitingNCT07085091Phase 1
• Metabolic Biomarkers Predicting Response to Neoadjuvant Immunotherapy in Non-Small Cell Lung CancerRecruitingNCT07084610Phase 2
• Lorlatinib in ROS1+ NSCLC With Brain MetastasisNot yet recruitingNCT07083687Phase 2
• Study of Oral EGFR Inhibitor DZD6008 Combined With Sunvozertinib in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN8)RecruitingNCT07079475Phase 1/2
• Prophylactic Proton Pump Inhibition for Esophageal Protection in Lung Radiation TherapyNot yet recruitingNCT07076914Phase 2
• Zusanli (ST36) Electroacupuncture Treatment for Neoadjuvant Immunotherapy in Non-Small Cell Lung CancerRecruitingNCT07076836Not applicable
• Bolstering Outcomes After Induction With Osimertinib Plus Chemotherapy Through Optimized Site-Directed Primary Tumor Therapy (BOOST Trial)RecruitingNCT07073365Phase 2
• Study of GV20-0251 in Participants With Solid Tumor MalignanciesRecruitingNCT07070518Phase 1/2
• DZD6008 Combination Therapy in Patients With Locally Advanced or Metastatic NSCLC With EGFR Mutation (TIAN-SHAN7)RecruitingNCT07070440Phase 1/2
• A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant TumorsRecruitingNCT07070232Phase 1/2
• Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced MalignanciesRecruitingNCT07064018Phase 1/2
• Phase I/II Study of PLB1004 Combined With Platinum-based Doublet Chemotherapy in Patients With EGFR Mutation-positiveNot yet recruitingNCT07063329Phase 1/2
• Analysis of Circulating Tumor Markers in Blood - ALCINA 5Not yet recruitingNCT07060950Not applicable
• Multiple Omics Sequencing Technologies in Predicting the Efficacy and Monitoring the Recurrence of Non-Small Cell Lung CancerRecruitingNCT07057102
• A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer and Other Solid TumorsRecruitingNCT07056556Phase 1
• Study of Atezolizumab in Advanced Non-oncogene-addicted NSCLC With PD-L1 ≥50%, Including Longitudinal c-FLIP Assessment in Monocytic MDSCs.Not yet recruitingNCT07051928
• Low Dose Nivolumab With Chemotherapy vs Standard Chemotherapy as First-Line Treatment in Advanced or Metastatic NSCLCRecruitingNCT07050043Phase 3
• A Study of LY4175408 in Participants With Advanced CancerRecruitingNCT07046923Phase 1
• PANK-003 Cell Injection Combined With Standard Adjuvant Chemotherapy After Surgery in Patients With Stage IIIA NSCLCNot yet recruitingNCT07043907Phase 2
• Exercise and Nutrition on Early-stage NSCLC Outcomes: the STARLighT StudyRecruitingNCT07042724Not applicable
• Oral Metronomic Vinorelbine and PD-1 Inhibitors in Elderly Non-small Cell Lung CancerRecruitingNCT07041320
• Early Palliative Care in Patients With Advanced Lung Cancer Using an e-Health EcosystemRecruitingNCT07039994Not applicable
• A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid TumorsNot yet recruitingNCT07036185Phase 1
• Efficacy and Safety of Chemoimmunotherapy and Carbon Ion Radiotherapy in Unresectable Locally Advanced Non-small Cell Lung CancerNot yet recruitingNCT07035860
• Enteral Nutrition With L-Carnitine for Cachexia in Non-Small Cell Lung CancerNot yet recruitingNCT07035444Not applicable
• A Study Evaluating the Efficacy of PD-1 Inhibitor Combined With Denosumab and Chemotherapy in Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Patients With Driver Gene-Negative StatusRecruitingNCT07034391Phase 2
• Risk and Prognosis of Brain Metastasis in Non-Small Cell Lung CancerNot yet recruitingNCT07034365
• Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung CancerRecruitingNCT07034326Phase 2/3
• A Single-arm, Multicenter, Prospective Clinical Study of Adebrelimab Combined With Apatinib Neoadjuvant Therapy for Resectable Non-small Cell Lung CancerNot yet recruitingNCT07031154Phase 2
• Study of CP-383 in Patients With Advanced or Metastatic Solid TumorsRecruitingNCT07030257Phase 1/2
• Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung CancerRecruitingNCT07028489
• A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung CancerRecruitingNCT07027514Phase 1

← Carcinoma, Non-Small-Cell Lung overview